摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S)-2,6-diaminohexanoic acid;2-hydroxybutanedioic acid | 93805-83-5

中文名称
——
中文别名
——
英文名称
(2S)-2,6-diaminohexanoic acid;2-hydroxybutanedioic acid
英文别名
——
(2S)-2,6-diaminohexanoic acid;2-hydroxybutanedioic acid化学式
CAS
93805-83-5
化学式
C10H20N2O7
mdl
——
分子量
280.28
InChiKey
NWZSZGALRFJKBT-JEDNCBNOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.57
  • 重原子数:
    19
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    184
  • 氢给体数:
    6
  • 氢受体数:
    9

文献信息

  • NUTRITIVE EMULSION
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP0312612A1
    公开(公告)日:1989-04-26
    The present invention provides a nutritive emulsion characterized in that the emulsion comprises essential components of about 4 to about 15% by weight of an amino acid preparation, about 3 to about 12% by weight of a lipid, about 71.5 to about 93% by weight of water, and about 0.3 to about 3.0% by weight of an emulsifier having an HLB of at least 13 and selected from the group consisting of sucrose fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester and polyoxyethylene sorbitan fatty acid ester, or an emulsifier mixture of said emulsifier and soybean lecithin and in that the emulsion has a pH of about 6.5 to about 8.5.
    本发明提供了一种营养乳剂,其特征在于该乳剂包括按重量计约4至约15%的氨基酸制剂、按重量计约3至约12%的脂质、按重量计约71.5至约93%的水、按重量计约0.3至约3.0%(重量)的乳化剂,该乳化剂的 HLB 至少为 13,并且选自由蔗糖脂肪酸酯、甘油脂肪酸酯、聚氧乙烯甘油脂肪酸酯和聚氧乙烯山梨糖醇酐脂肪酸酯组成的组,或上述乳化剂和大豆卵磷脂的乳化剂混合物,乳液的 pH 值为约 6.5 至约 8.5。
  • Nutrient-supplying preparation
    申请人:THE GREEN CROSS CORPORATION
    公开号:EP0671166A2
    公开(公告)日:1995-09-13
    Disclosed is an infusion preparation for nutrient supply use. It comprises a sugar, amino acids, electrolytes and a fat emulsion. It has an excellent shelf life without causing precipitation, denaturation and the like in spite of the simultaneous presence of these components. Also disclosed is a container filled with infusion liquids comprising a first and a second compartments separated from each other by a separation means, wherein an infusion liquid containing a fat emulsion and a sugar is included in the first compartment and another infusion liquid containing amino acids and electrolytes is included in the second compartment. Further disclosed are an infusion preparation comprising a fat emulsion and a sugar, and an infusion preparation comprising amino acids and electrolytes. An infusion preparation containing a sugar, amino acids, electrolytes and a fat emulsion can be obtained easily and aseptically upon use, by simply removing a separation means attached to the container and mixing the two infusion liquids.
    本发明公开了一种用于营养供应的输液制剂。它由糖、氨基酸、电解质和脂肪乳液组成。尽管这些成分同时存在,但它具有极佳的保质期,不会引起沉淀、变性等现象。本发明还公开了一种装有输液的容器,该容器包括通过分离装置相互隔开的第一和第二隔室,其中第一隔室中装有一种含有脂肪乳液和糖的输液,第二隔室中装有另一种含有氨基酸和电解质的输液。进一步公开了一种包含脂肪乳液和糖的输液制剂,以及一种包含氨基酸和电解质的输液制剂。使用时,只需取下附在容器上的分离装置,将两种输液混合,即可方便无菌地获得含有糖、氨基酸、电解质和脂肪乳液的输液制剂。
  • NUTRITIONAL TRANSFUSION FOR PERIPHERAL VEIN ADMINISTRATION
    申请人:THE GREEN CROSS CORPORATION
    公开号:EP0700681A1
    公开(公告)日:1996-03-13
    A nutritional transfusion that can be administered via peripheral veins and is improved in stability and conservability. It contains a saccharide, an amino acid, an electrolyte and a fat emulsion each in a specified proportion and has specified pH value and titratable acidity. It has a good conservability because it is free from precipitation and denaturation in spite of its composition comprising the above various components. Further it is free from the problem of angialgia or the like even when administered via peripheral veins, since it has a specified pH value and a low titratable acidity.
    一种可通过外周静脉输注的营养输液,其稳定性和保存性均有所提高。它包含一种糖、一种氨基酸、一种电解质和一种脂肪乳液,每种物质都有规定的比例,并有规定的 pH 值和可滴定酸度。它具有良好的保存性,因为尽管其成分包括上述各种成分,但它不会发生沉淀和变性。此外,由于它具有特定的 pH 值和较低的可滴定酸度,因此即使通过外周静脉给药,也不会出现血管痛等问题。
  • TRANSFUSION CONTAINER, TRANSFUSION PREPARATION, AND COMPREHENSIVE VITAMIN-CONTAINING HIGH-CALORIE TRANSFUSION PREPARATION
    申请人:THE GREEN CROSS CORPORATION
    公开号:EP0704199A1
    公开(公告)日:1996-04-03
    A transfusion container useful for preparing a transfusion containing saccharide, amino acid, electrolyte, fat emulsion and vitamin. The container is composed of two compartments with a partitioning means provided therebetween, and a first compartment contains a transfusion containing fat emulsion, saccharide and specified vitamin, while a second compartment contains a transfusion containing amino acid, electrolyte and other specified vitamin. A transfusion preparation containing saccharide, amino acid, electrolyte, fat emulsion and vitamin can be readily and aseptically prepared by removing the partitioning means prior to use and mixing the transfusions contained in the two compartments together.
    一种输液容器,用于配制含有糖、氨基酸、电解质、脂肪乳液和维生素的输液。该容器由两个隔室组成,隔室之间设有分隔装置,第一隔室装有含脂肪乳剂、糖和特定维生素的输液,第二隔室装有含氨基酸、电解质和其他特定维生素的输液。在使用前移除分隔装置并将两个隔室中的输液混合在一起,就可以方便无菌地制备含有糖、氨基酸、电解质、脂肪乳液和维生素的输液制剂。
  • ANALGESIC ACTIVITY ENHANCER
    申请人:OTSUKA PHARMACEUTICAL FACTORY, INC.
    公开号:EP0740935A1
    公开(公告)日:1996-11-06
    The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino acid composition (%); leucine 8.0 - 16.0, isoleucine 4.0 - 9.0, valine 4.0 - 9.0, lysine 6.0 - 13.0, threonine 3.0 - 6.0, tryptophan 1.0 - 2.0, methionine 2.0 - 5.0, cysteine o.5 - 2.0, phenylalanine 3.0 - 7.0, tyrosine 0.2 - 1.0, histidine 2.0 - 5.0, arginine 30.0 - 60.0, alanine 0.5 - 2.0, aminoacetic acid 0.5 - 2.0, serine 0.2 - 1.0, proline 0.5 - 2.0, aspartic acid 0.1 - 0.5 and glutamic acid 0.1 - 0.5, calculated as free amino acids. The analgesic effect enhancing preparation of the present invention potentiates analgesic effect of various analgesics.
    本发明提供了一种能够增强镇痛药效果的镇痛效果增强制剂,该制剂作为有效成 分包括以下氨基酸组成(%);亮氨酸 8.0 - 16.0,异亮氨酸 4.0 - 9.0,缬氨酸 4.0 - 9.0,赖氨酸 6.0 - 13.0,苏氨酸 3.0 - 6.0,色氨酸 1.0 - 2.0,蛋氨酸 2.0 - 5.0,半胱氨酸 o.5- 2.0, 苯丙氨酸 3.0 - 7.0, 酪氨酸 0.2 - 1.0, 组氨酸 2.0 - 5.0, 精氨酸 30.0 - 60.0, 丙氨酸 0.5 - 2.0, 氨基乙酸 0.5 - 2.0, 丝氨酸 0.2 - 1.0, 脯氨酸 0.5 - 2.0, 天门冬氨酸 0.1 - 0.5 和谷氨酸 0.1 - 0.5(以游离氨基酸计算)。 本发明的镇痛效果增强制剂可增强各种镇痛药的镇痛效果。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物